Good morning, and welcome to the 2026 Ultimate Services Conference. My name is Michael Cho, and I am an equity analyst here at JP Morgan, covering Nasdaq. This morning, we have Sarah Youngwood, the CFO of Nasdaq. Sarah, it is wonderful to have you here.
Thanks for having me.
It is a fun time at Nasdaq.
Very good.
There seems to be a lot of good things happening. Maybe you will tell me how many cylinders it is running on. But look, we have about 30 minutes for the fireside chat here. I will run for about 20 minutes, and I will leave the last 5-10 minutes for audience Q&A. I think we have a mic that is going to come, so think of questions. I will open it up in a little bit, and please wait for the mic. I feel like it is a big AI week. I have a bunch of questions. I promise they are not all about AI, but let me just start broadly on Nasdaq. 2026 has been a wonderful year in terms of revenue growth and revenue growth acceleration. As you look, we sit here in late November.
As you look into 2027, can you just talk through about what is getting you excited about 2027, where you see some clear inflections, and where you see momentum sustained as we look into 2027 as we transition here?
Yeah. As we enter in 2027, what we are seeing is durable structural trends that are very supportive. You have seen that in our numbers, whether it is last quarter, or even the first two quarters of the year. Last quarter was 14% revenue growth with 18% in Solutions revenue, 14% in ARR growth with 18% in FinTech, double digit across all of the subdivisions in FinTech. So a lot of growth, combined with operating margin. What we are seeing is that our clients are looking to us for core infrastructure as that transforms, as well as AI needs. Lastly, Always-On is creating a lot of opportunities for us. So, it is really well-positioned for Nasdaq to be at this intersection of AI, digital assets across core infrastructure, and the demands of markets.
Great. You gave us a lot. I am going to touch on some of those topics one by one, and I will jump around a little bit. But you ended with Always-On markets, right? Part of that is you have the 23/5 coming on pretty shortly, but tokenization is another big initiative that is underway at Nasdaq and underway broader ecosystem as well. So, I think the Nasdaq Equity Token is coming in early or sometime 2027.
Yes.
We can debate the good, the bad, and maybe the pace of the initiatives, as it relates to Nasdaq. Was wondering if you can kind of talk through how you are approaching adoption of this initiative and how you see the ecosystem unfolding, 2027 and beyond.
Yeah. The major principles that we have always stood by, we are continuing to stand by, which is you need to have integrity, liquidity, and transparency to the capital markets. Others are creating parallel markets, and we really believe in making sure that you have one unified pool of liquidity, that is not competing with the core market. Really embedding the Nasdaq Equity Token in the current rails of the market and making sure that there is full ownership, there is full right to one CUSIP, there are all of the rights associated with the CUSIP that are associated with the token.
As such, we have partnered with DTCC, with Kraken, to make sure that solutions are benefiting from the ledger, which would be the mobility, the collateral, all of the capital and liquidity benefits that go with that, as well as the composability, which is going to enable the issuers and the investors to grow closer together. For us, there is only good because you are not sacrificing that liquidity pool through our solutions.
When we think about pace hereâ
Yep.
âright? Is this, in your mind, one, how do you think about the pace from here in terms of the ecosystem developing? Then maybe I'll just fast-forward five- plus years. What does a mature system look like, and pace of how you think we get there?
Yeah. You start with, you have a genuine trend towards Always-On, with the first step being 23/5 in December 6. That's just like creating demand for all of those instruments being tokenized. The second piece is first half of 2027, we will have this Nasdaq Equity Token, and it's going to start, we believe, with some forward-leaning issuers. So we're not expecting that it would be widely adopted on day one, but we are getting very good receptivity from some very, very good listed companies. Then you move, and it's over the course of years, and so thanks for the question being five years, that you end up gradually going in this fiat and token environment. I'm not even saying that five years from now, you have no fiat.
Even at a five-year horizon, you're still in this hybrid environment, but you have created a real benefit from having access to all of the beauties of the current capital markets and its benefits in the token form.
So there are a few other competing initiatives or platforms out there. When you talk to your clients that seem to be more forward-leaningâ
Yeah.
âwhy are they more forward-leaning with you, maybe relative to some others out there in the market? What else are you hearing in terms of how one platform might be better or worse than others?
Yeah. Our belief is that our solution does not actually have the high cost that would be associated with breaking the liquidity pool. Think of it as an option with a very simple way of entry that does not actually move you into breaking your liquidity pool, having the liquidity, and therefore the volatility that could come of it, the complexity that could come with it. The strength of our solution is that it's not a big ask, and it provides the value of the token without the high cost of breaking the liquidity pool. Therefore, when an issuer is comparing a solution that is breaking the liquidity pool to our solutions that really leverages all of the benefits of the current rails of the capital markets, it's a very simple decision because you're getting the same benefits without the very high cost.
Yeah. That's great. Let me switch gears. I want to talk about AI. I want to talk about the impact across Nasdaq. Maybe I'll just pick one of the businesses. I'll just start with Verafin. Verafin, it's got four AI agents now, I think it is. Maybe it's heading to six.
Yeah, and two in pilot.
Yeah. So two in pilot.
Yes.
And I think you've recently talked about almost 1,000 clients, or sorry, it's 850.
850.
850 with AI solutions. How we think about the source of, and this is really more of a Verafin question. When we think about the source of the operating momentum inside Verafin, and we think about the AI impact and the modules and the releases that's having, and pricing at some point, versus the enterprise clients that are coming on board, how would you frame in terms of the operating momentum at Verafin that's coming on board in the next 12- 24 months?
Yeah. So we have very strong momentum at Verafin, I would say. What's driving that is, first of all, the need. There is urgency by our clients around the topic of financial crime management, and there is a real realization at this point by both the small banks as well as the largest banks that you can't go at it alone, that there is a value to the consortium that we have assembled. It is 2,800 banks, $13 trillion in assets represented by those banks. And so by having that transparency, we are able to really see through very complex fraud. For example, there is a situation where we found across 45 banks, 8,000 fraud, and we're able to kind of like see that map because of the strength of our data, even though all of those behaviors are very, very different.
We think that it is extremely powerful to have that. When you then translate that into growth drivers, you have the durable trends associated with our small and medium-sized businesses. You add to that the very strong signings that we have had in the enterprise. Last year was nine. In the first three quarters of this year, it was already 12. All of those signings take time to get into the ARR and the revenue, 6-1 2 months. But when that happens, you are translating that into revenue and then ARR, and that gives you that recurring additional driver for growth. Then lastly, as you said, GenAI, with all of the numbers you talked about, 850 clients out of the 2,800, 70 that are already paying.
That continues to drive, and it is part of our land- and- expand strategy, expanding the AI part.
That is fair. Do you think clients are coming in terms of, you still add 50+ new clients every quarterâ
Yeah.
âto Verafin. Is there a portion of that client base that you think is incremental given the AI capabilities that is in place now, or is it a little too early at this point?
Well, it's certainly part of the conversation when we go to our new clients and to our existing clients, that we can help them, of course, with our consortium data. We also have a very modern UX as well as series of agents. Not only do we help them in catching the fraud better, proven by all the POCs and the experience we have with our clients, but in addition, we catch it quicker, and we catch it now through the agents with an agentic workforce that can truly help them on their efficiency plans. When you have that tripod of being better, faster, and cheaper, you definitely catch the eye of your existing clients in terms of retention and adding to their spend with us, as well as with new clients.
Yeah. No, that's fair, and that makes sense. Maybe I'll kind of different flavor, same topic, right? I think we can't go a week or two without a headline of an AML violation or some sort of fraud financial crime that's happening across the banks. I think investors have taken this and this concept of maybe accelerating or increasing crime and fraud, it's like maybe this should be ultimately a benefit for Verafin, if not today, over time. My question is, the headlines are there, the crime is happening. Is this impacting sales cycles at all for Verafin yet?
The urgency is there. Verafin and Nasdaq in general are viewed as a trusted partner, trusted by our clients for our investments in trust and security. We are also very much a regulated entity ourself, not on the financial crime front, but we are, and we work with market operators and regulators. That very broad trust associated with Nasdaq is incredibly important to our clients. So, that's one thing. The second thing is, even when you really want something, because we're touching the most critical part of confidential MNPI data for clients, we have to go through the steps, so that decision is not a light decision. The acceleration in sales cycles is not something that we're seeing today.
We're seeing very strong demand, very strong urgency around our products, very strong desire to do business, but not to the point of sacrificing the steps that are important steps that our clients take when they make such a decision on such particular data.
No, that's great. If I just zoom out on that point you made in terms of regulatory and expectations. I guess more broadly, the regulatory expectations around AML and fraud seems to be becoming more highly sensitive.
As it should be.
Fair enough. As that continues to evolve, I mean, apart from just being in the system and integral to your clients in terms of what Verafin is bringing, do you envision maybe a broader role for Verafin to play in the ecosystem? Like, for example, Verafin helps run the FRAMLxchange today, which is a marquee thing that the financial institutions come together and create a utility for.
That's right.
My question is there something more broader that you think Verafin can do here as these heightened expectations continue?
Yeah. What's really important is that we are trusted. We take our time to go through the contracting as well as the integration, and that integration for smaller banks is in 70 core banking systems. It's actually quite complicated to do. You've got both the relationship as well as the difficulty of the integration. But once you have that integration, you can do more. In some ways, that bar, once met, creates your moat. We have a very strong retention for Verafin. We have the ability to do more. Of course, we're not resting on our laurels. Because we're very innovative, because we are showing them the solutions, we can do more. The financial crime management is a real topic, both in terms of, it has a cost. The cost of fraud is in your P&L as a bank CFO.
You will care about addressing that. It's also in your efficiencies. Lastly, as you said, it's a regulatory risk that has a very, very large cost. Real demand drivers, we see that as very structural. We see that as actually being broader than just the U.S., with the notion of consortium also becoming more of a reality in parts of Europe.
Yeah. Makes sense. Maybe I'll just continue on AI and move on from Verafin. Broadly speaking, Nasdaq, like you said, there's a lot of AI initiatives happening internally as well as from a client perspective as well. I mean, if you think about from the investor perspective, is there kind of a neat way to frame the current, I guess, top- line impact that these AI initiatives are generating for Nasdaq today?
Yeah. The way I think about it is AI is really three ways of monetization. The first one is when we talk to you about the agentic workforce of Verafin, for example, which I just mentioned, those agents have a cost, and so it's an add-on. It's a cost times the 70 clients that are paying and more to come. That's a very real monetization. I will say, our freemium strategy is very much working. The first thing we do is we establish the trust, we show the value, and then we monetize. That cycle of freemium to paying is starting to convert at Verafin. Then with the same model, we are getting started in Calypso and in surveillance, in AxiomSL, but they are steps behind and still in the freemium part of the strategy. Then you go to the second part, which is data.
Data is incredibly important when it is the data that you cannot purchase, contributory data, consortium data, and when you are in need of this data, you need it very real-time, to feed your GenAI models or other things for your clients. So, we have MCP connectors, which are in addition to the value of the data we can charge for the MCP connection, and that's a second way of monetization in eVestment. We had 25% of our bookings being GenAI, for example, last quarter. Then the third element is GenAI as a reason to go cloud. There has been a long series of years where institutions have gotten more and more comfortable with cloud, and at this point, I would say 90%, 95% of institutions are comfortable with cloud. But it's a conversion, and like any conversion, you need to have a trigger.
That trigger right now is very often GenAI. When people see our capabilities, which we offer through GenAI, and the ease of having the efficiencies that come with it, people have one more reason, there are many other reasons to go to cloud, to do that, and with that comes higher ACV.
Yeah. Can I just ask, you mentioned MCPs, so the Data Link MCP launched notâ
Yeah.
ânot that long ago. Can you just talk through adoption trends there? I mean, you were pretty clear in that this is an incremental pieceâ
Yep.
âto whatever the clients are receiving today. Maybe if you want to frame how much incremental and then maybe just talk through adoption.
Yeah, so we're not saying specifically how much more. But what you can see is that we have our regular price, but then we charge for the specific connectivity on a per-month basis if you want to have that MCP connectivity. Whether you're talking about our proprietary market data, if you want to conduct research and deliver it at the fingertips of your retail clients, for example, if you're a retail brokerage or if you are a company who FinTech and delivers to retail, you want to integrate that data, but not like in yesterday's data. You want that real-time data, and you're willing to pay more to have it delivered that way. If you are in investment and you want to analyze the data through your GenAI agents, we're going to be much more token- efficient in a patented way.
And so, yes, you can pay for the UX of the platform, but those graphs are very token- inefficient, as would be any graphs. And so we sell it to you in this much easier to consume way, and you save on token, you pay us. Those are examples. Data Link also is delivered that way, for example, to hedge funds who want to trade immediately on the data.
Yeah. Oh, that is great. We have about eight minutes left. I just want to make sure, I will open up the questions now. If you have a question, just raise your hand, and we will take a mic over.
No, it is actually on the table.
Oh, it is already on the table. Okay. If you have a question, just raise your hand, and then we will call on you. As you are thinking of questions, let me go ahead.
Looking at the Investor Day presentation, there was, I think, in Financial Technology, there was a $28 billion serviceable addressable market.
$38 billion.
Huh?
$38 billion even.
$38 billion, sorry. Can you talk about the efforts to get after that, because I believe the numbers that are being achieved are showing that it's going to take a long, long time to potentially really get after that total addressable serviceable market, and things that could be done to kind of accelerate that effort.
Yeah, I love the question. One of the really exciting part of AI is our ability to expand into that SAM. We've got this $38 billion SAM. We can really penetrate it much better. I'll give you an example. In our capital market stack, as an extension to Calypso, we really built out a solution on ETD clearing. That's something which was, I would say, loosely part of our SAM, but that we didn't have as much of a right to win as some other players. We built a solution with HSBC, and with that comes a real right to win, not only the ACV that we're getting with that particular client, but the ability to have additional ACV from other clients in that category. If you look at the time to build, it has really compressed.
When we talked about some adjacencies, which I didn't specifically mention, but which we're working on Verafin, things that could have been a two-year build can be actually accomplished in months. Things that might have been much more of something that you can't enter organically can become organic. We are very focused on the penetration of that $38 billion SAM, and we're seeing great success, and you're seeing that in the acceleration. If you're thinking of the market itself growing about at 9%, which is what we said at Investor Day, and you're comparing that to our 18% Solutions revenue last quarter, or even our 14% total revenue growth, we have been very much outpacing the markets, which shows you our penetration within.
Go ahead.
Yeah. We've all heard about the statistic of the number of public companies from 8,000 [inaudible] to less than 4,000 [inaudible]. What are the three biggest [inaudible]
We are seeing actually that there is a current today towards making it a bit simpler and a bit easier, a bit less risky to be a public company. We very much welcome those efforts and have been supporting those. Whether it is about the disclosure, whether it is about the different risks that are being addressed, we think that there is good progress there. When you think about the U.S. capital markets, we are talking about a $90 trillion ecosystem. It's extraordinary. It's more than half what we are seeing in the entire world, with the next largest being around 16%. All of Europe together would be 16%, but it's not a unified market. If you're looking for a large amount of liquidity, you have the public market.
When you are thinking about it from the point of view of the exits, the private markets are, of course, very strong, but they get to the point where at this point we have not had a very large number of exits, and therefore there is real demand from both the issuers and their owners for the very large pools of capital that I just mentioned that are in the public market. We have a very, very strong pipeline. It's very well diversified, of course, AI and the AI suite, but also healthcare, even some on defense. We are seeing that there is a broad interest in being public, and that there is a very broad interest in being public in the U.S. on Nasdaq.
Maybe I will ask you on the other side. You mentioned, public markets one side. You also have a business that caters to the private markets as well, as you mentioned.
Yeah.
eVestment provides private market data.
Yeah.
It provides solutions for various asset owners or asset managers as well. Can you just talk through the different points in which Nasdaq caters or touches the private market world? Then in terms of eVestment specifically, where does eVestment get the private market data, and how are you kind of positioned to, again, service that secular demand that is happening on the private market side?
Yeah. We really think of it as a continuum. There is a stage at which it totally makes sense for companies to be private, and then there is a stage at which it makes sense for them to become public. We help companies through that continuity, and we help investors having more transparency through that continuity. On eVestment, we now have 95,000 funds data that is available. What is great is that we distribute it in the exact same way as your public data. You can basically, in your same platform, see one and the other. A lot of investors now are crossover, especially in the pre-public round. That is a very important component of our strategy to be very easy to use, and it is coming across.
We also help the private companies themselves through in Ventures, eVestment in Nasdaq Private Market, so whether it is getting secondary liquidity for employees, and we are the number one in that, whether it is fund secondaries, some of the LPs might want to have some liquidity. All of that is something that we facilitate through Nasdaq Private Market or Ventures portfolio. Even in index, we are looking at the right way to think about indexing on private opportunities, and that passive trend is going to continue to expand to be, of course, mostly on public, but also with a component in private.
Okay. That's great. Anything else from the audience? We got a minute left. I'm going to ask you about capital, your favorite question.
Always.
Nasdaq, about $2.5 billion of free cash flow. I don't think you're delevering that much more, other than growing earnings and growing EBITDA. If we think about the uses of capital going forward, there's a slug for dividends, less of a slug for debt paydown, if any. There's ample flexibility. You've done buybacks, you have done or are doing an ASR now. I guess, one, can you just remind us the parameters for what a bolt-on consists of and what a tuck-in consists of? Then two, just broadly, how we should think about in terms of buyback pace or capacity?
Yeah. With over $2 billion of free cash flow, as you said, we have ample flexibility and the ability to do a lot. If you look at everything we've talked about, and despite having 57% of operating margin, 60% of EBITDA margin, this is really funding a very high level of investments in our organic growth. Really love the question on how are we penetrating our SAM. This is something that is our number one focus and priority. But by the time you have done that, you are still left with this very ample free cash flow. We will continue to have a progressive dividend, that goes without saying, and you've seen us do that consistently over the years.
When you get to leverage, as you mentioned, we are within our target range, therefore don't need to do anything extraordinary other than continuing to grow our EBITDA and our earnings in general. Then, you get to share repurchases. As a reminder, this year we have done through the first three quarters, so in three quarters, $1.2 billion, which is twice what we had done last year. We announced that we were also launching a variable ASR that would add somewhere between $315 million and $385 million of share repurchases. So, we are set to have a solid year in share repurchases, and we have been very interested in having that as a core part of our portfolio. Then on M&A, we've been very clear that despite the focus on organic growth, we would do tuck-ins, and in fact, bolt-ons also.
Tuck-ins we have done. So LeveL Markets, and we didn't talk about that, but a very key part of our Always-On market strategy is a tuck-in. It was a small acquisition. If we don't need to tell you how much it costs in general, a tuck-in would be the right description for Dasseti as an add-on to eVestment was also a tuck-in. A bolt-on, we would probably tell you how much it is, but you would view that as highly digestible within our ability to execute quickly.
Perfect. Let's stop here. Thank you, Sarah. Thanks for joining us. Let's end.